The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Lamotrigine in the acute treatment of bipolar depression: results of five double‐blind, placebo‐controlled clinical trials
Abstract
Objectives: The efficacy of lamotrigine as maintenance treatment for bipolar disorder (BD), particularly for delaying depressive episodes, is well established, but its efficacy in the acute treatment of bipolar depression is less clear. This paper reports the results of five randomized, double‐blind, placebo‐controlled trials of lamotrigine monotherapy for the acute treatment of bipolar depression. Methods: Adult subjects with bipolar I or II disorder experiencing a depressive episode were randomized to placebo or lamotrigine monotherapy (after titration, at a fixed dose of 50 mg or 200 mg daily in Study 1; a flexible dose of 100–400 mg daily in Study 2; or a fixed dose of 200 mg daily in Studies 3, 4 and 5) for 7–10 weeks. Results: Lamotrigine did not differ significantly from placebo on primary efficacy endpoints [17‐item Hamilton Depression Rating Scale in Studies 1 and 2; Montgomery–Asberg Depression Rating Scale (MADRS) in Studies 3, 4 and 5]. In Study 1, lamotrigine significantly separated from placebo on some secondary measures of efficacy, including the MADRS, the Clinical Global Impressions‐Severity (CGI‐S) and the CGI‐Improvement (CGI‐I), but seldom differed on secondary efficacy endpoints for the other studies. Conclusions: Lamotrigine monotherapy did not demonstrate efficacy in the acute treatment of bipolar depression in four out of five placebo‐controlled clinical studies. Lamotrigine was well tolerated in the acute treatment of bipolar depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Self-citationGoodwin, G. M., Bowden, C. L., Calabrese, J. R., Grunze, H., Kasper, S., White, R., Greene, P., & Leadbetter, R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0321 · Cited by 581 · cited 1×
“1) White race, n (%) Lamotrigine 57 (90) 90 (87) 113 (88) 70 (64) 94 (74) Placebo 62 (94) 89 (86) 99 (84) 82 (75) 84 (69) Female, n (%) Lamotrigine 35 (56) 66 (64) 74 (57) 70 (64) 69 (54) Placebo 39 (59) 61 (59) 62 (53) 69 (63) 66 (54) Duration of current episode in weeks, n (%) Lamotrigine £ 24 49 (78) 79 (77) 104 (8…”
Self-citationClinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L., et al. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1106 · Cited by 498
Self-citationA Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Demographic and Clinical Characteristics of Individuals in a Bipolar Disorder Case Registry
Kupfer, D. J., Frank, E., Grochocinski, V. J., Cluss, P. A., Houck, P. R., & Stapf, D. A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0206 · Cited by 294 · cited 2×
“Depression is also associated with greater intra- and inter-episodic morbidity (5–8) and mortality (8, 9).”
BackgroundValproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
Macritchie, K., Geddes, J., Scott, J., Haslam, D. R., & Goodwin, G. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003196 · Cited by 263
Effect of number of episodes on wellbeing and functioning of patients with bipolar disorder
MacQueen, G. M., Young, L. T., Robb, J. C., Marriott, M., Cooke, R. G., & Joffe, R. T. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101005374.x · Cited by 151
Research works printed but not linked: 23
- Anonymous, 2002, Bipolar depression and rapid cycling: the latest pharmacologic strategies, Brown Univ Child Adolesc Psychopharmacol, 13, 10
- 10.1034/j.1399-5618.2000.20306.x · DOI
- 10.2165/00023210-200317010-00002 · DOI
- 10.1016/S0022-3956(97)00030-7 · DOI · Paper page
- 10.1176/ps.50.2.201 · DOI
- 10.1176/ajp.151.7.1020 · DOI · Paper page
- Calabrese JR, 2002, Long‐term treatment of bipolar disorder with lamotrigine, J Clin Psychiatry, 63, 18
- Burgess S, 2001, Lithium for maintenance treatment of mood disorders (Cochrane Review), Cochrane Database Syst Rev, 2, CD003013
- 10.1001/archpsyc.1976.01770010073014 · DOI
- 10.1016/S0924-977X(99)00023-1 · DOI
- 10.1097/00004714-199612000-00003 · DOI
- Compton MT, 2000, The treatment of bipolar depression, J Clin Psychiatry, 61, 57
- 10.1192/bjp.164.4.549 · DOI · Paper page
- American Psychiatric Association, 2002, Practice guidelines for the treatment of patients with bipolar disorder, Am J Psychiatry, 159, 1
- 10.1001/archpsyc.60.4.392 · DOI · Paper page
- 10.4088/JCP.v64n0906 · DOI · Paper page
- 10.1176/ajp.156.7.1019 · DOI · Paper page
- 10.1016/S0006-3223(99)00013-X · DOI
- 10.2165/00002018-200427030-00002 · DOI
- 10.2165/00023210-200418010-00007 · DOI
- Geddes J, 2006, Bipolar Disord, 32
- 10.1345/aph.1D172 · DOI
- 10.1097/01.NMD.0000061144.16176.38 · DOI
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
“Lamotrigine monotherapy was not superior to placebo in four double blind placebo controlled trials of acute bipolar depression on the primary outcome (254).”
BackgroundMethodResultInfluentialSelf-citationYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Diazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“No increased rate of switching compared with placebo has been found in other trials of monotherapy with lamotrigine (Calabrese et al., 2008; Geddes et al., 2009), second generation antipsychotics (quetiapine, olanzapine, aripiprazole, ziprasidone) (De Fruyt et al., 2012), or lithium (Young et al.,…”
ResultYatham, L. N., Kennedy, S. H., Schaffer, A., Parikh, S. V., Beaulieu, S., O'Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., Ravindran, A., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00672.x · Cited by 570
Self-citation
Metadata
- Authors
- Calabrese, J. R., Huffman, R. F., White, R. L., Edwards, S., Thompson, T. R., Ascher, J. A., Monaghan, E. T., & Leadbetter, R. A.
- Venue
- Bipolar Disorders
- Publisher
- Wiley
- Published
- 2008-02-06
- Volume
- 10
- Issue
- 2
- Pages
- 323-333
- ISSN
- 1398-5647 (ISSN-L)
- 1399-5618
- OpenAlex
- W1977252830
- Cited by
- 248
- References
- 11
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lamotrigine in the acute treatment of bipolar depression: results of five double‐blind, placebo‐controlled clinical trials. https://app.cochat.ai/papers/10.1111/j.1399-5618.2007.00500.x
- The paper
- Calabrese, J. R., Huffman, R. F., White, R. L., Edwards, S., Thompson, T. R., Ascher, J. A., Monaghan, E. T., & Leadbetter, R. A. (2008). Lamotrigine in the acute treatment of bipolar depression: results of five double‐blind, placebo‐controlled clinical trials. Bipolar Disorders. https://doi.org/10.1111/j.1399-5618.2007.00500.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.